AFTX-201 uses a proprietary capsid to deliver a human BAG3 transgene, aiming to restore cardiac function with lower doses than conventional gene therapies.

HealthDay News — A growing number of states are rolling back financial help for HIV medications. An analysis released March 2 by the health research group KFF found that 18 states have adopted ...

No significant improvement seen in overall survival with addition of hormone therapy to post-radical prostatectomy radiotherapy.

HealthDay News — Microplastics have been found in most prostate tumors, according to a small study presented at the American Society of Clinical Oncology annual Genitourinary Cancers Symposium, held ...

HealthDay News — Among young adults, first ST-segment elevation myocardial infarction (STEMI) in-hospital mortality increased from 2011 to 2022, according to a study published online February 26 in ...

HealthDay News — Daily aspirin use does not offer a reliable way to prevent colorectal cancer (CRC), according to a review published online February 26 in the Cochrane Database of Systematic Reviews.

Prevalence of hypertension, diabetes, and obesity estimated to increase, while hypercholesterolemia set to decline ...

In the phase 3 VERIFY trial, rusfertide was associated with a significantly higher proportion of patients achieving clinical response compared with placebo.

The FDA grants Priority Review to brepocitinib for dermatomyositis after trial results show significant muscle and skin improvements in patients.

Incidence rates increased by 3% annually among adults aged 20 to 49 years and by 0.4% annually for those aged 50 to 64 years.

HealthDay News — The prevalence of obesity and severe obesity markedly increased among adults and children in the US from the 1970s and 1980s until now, according to two reports published in the ...

Review reveals refusal tied to significantly higher risk for life-threatening brain bleeds and long-term neurological disability.